Growth Metrics

Progyny (PGNY) Receivables - Other (2018 - 2025)

Progyny (PGNY) has disclosed Receivables - Other for 8 consecutive years, with $33.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Receivables - Other changed N/A to $33.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $33.9 million, a N/A change, with the full-year FY2025 number at $33.9 million, changed N/A from a year prior.
  • Receivables - Other was $33.9 million for Q4 2025 at Progyny, down from $44.3 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $76.5 million in Q2 2024 to a low of $23.2 million in Q1 2021.
  • A 5-year average of $44.7 million and a median of $45.1 million in 2023 define the central range for Receivables - Other.
  • Peak YoY movement for Receivables - Other: skyrocketed 164.92% in 2022, then plummeted 35.69% in 2025.
  • Progyny's Receivables - Other stood at $23.7 million in 2021, then surged by 81.01% to $42.9 million in 2022, then rose by 5.13% to $45.1 million in 2023, then surged by 31.93% to $59.5 million in 2024, then plummeted by 43.03% to $33.9 million in 2025.
  • Per Business Quant, the three most recent readings for PGNY's Receivables - Other are $33.9 million (Q4 2025), $44.3 million (Q3 2025), and $49.2 million (Q2 2025).